Loading...
Memphasys Limited
MEM.AX•ASX
Healthcare
Biotechnology
A$0.004
A$0.00(0.00%)
Memphasys Limited (MEM.AX) Financial Performance & Income Statement Overview
Review Memphasys Limited’s income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns.
Revenue Growth
290.35%
↑ 290.35%
Operating Income Growth
-44.17%
↓ 44.17%
Net Income Growth
-30.55%
↓ 30.55%
Operating Cash Flow Growth
-129.72%
↓ 129.72%
Operating Margin
-1111.02%
↓ 1111.02%
Gross Margin
-90.69%
↓ 90.69%
Net Profit Margin
-1461.72%
↓ 1461.72%
ROE
-79.09%
↓ 79.09%
ROIC
-60.79%
↓ 60.79%
Memphasys Limited (MEM.AX) Income Statement & Financial Overview
Review Memphasys Limited's (MEM.AX) income statement with detailed quarterly and annual figures.
| Metric | Q2 2025 | Q4 2024 | Q2 2024 | Q4 2023 |
|---|---|---|---|---|
| Revenue | $325344.00 | $24000.00 | $36000.00 | $11100.00 |
| Cost of Revenue | $50593.00 | $615582.00 | $1.07M | $719837.00 |
| Gross Profit | $274751.00 | -$591582.00 | -$1.03M | -$708737.00 |
| Gross Profit Ratio | $0.84 | -$24.65 | -$28.71 | -$63.85 |
| R&D Expenses | $784057.00 | $1.44M | $700379.00 | $954100.00 |
| SG&A Expenses | $625021.00 | $717130.00 | $757825.00 | $719054.00 |
| Operating Expenses | $1.41M | $2.21M | $1.46M | $1.67M |
| Total Costs & Expenses | $1.46M | $2.77M | $2.53M | $2.39M |
| Interest Income | $0.00 | $0.00 | $6105.00 | $7778.00 |
| Interest Expense | $0.00 | $295639.00 | $121494.00 | $249060.00 |
| Depreciation & Amortization | $69665.00 | $391559.00 | $325604.00 | $553960.00 |
| EBITDA | -$1.60M | -$1.45M | -$1.86M | -$1.42M |
| EBITDA Ratio | -$4.93 | -$60.51 | -$51.54 | -$164.68 |
| Operating Income | -$1.13M | -$2.75M | -$2.49M | -$2.38M |
| Operating Income Ratio | -$3.49 | -$114.46 | -$69.22 | -$214.58 |
| Other Income/Expenses (Net) | -$1.83M | $607434.00 | $189275.00 | -$1.07M |
| Income Before Tax | -$2.97M | -$2.14M | -$2.30M | -$2.22M |
| Income Before Tax Ratio | -$9.12 | -$89.15 | -$63.96 | -$199.92 |
| Income Tax Expense | $0.00 | $0.00 | -$4.00 | $0.00 |
| Net Income | -$2.97M | -$2.14M | -$2.30M | -$2.22M |
| Net Income Ratio | -$9.12 | -$89.15 | -$63.96 | -$199.92 |
| EPS | -$1.90 | -$0.001 | -$0.002 | -$0.002 |
| Diluted EPS | -$1.90 | -$0.001 | -$0.002 | -$0.002 |
| Weighted Avg Shares Outstanding | $1.56M | $2.31B | $1.13B | $1.002B |
| Weighted Avg Shares Outstanding (Diluted) | $1.56M | $2.31B | $1.13B | $1.002B |
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan